Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    17362317 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial
Conditions: Epithelial Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Carcinoma
Interventions: Drug: Paclitaxel(intravenous) + Carboplatin(intravenous);   Drug: Paclitaxel(intravenous) + Carboplatin(intraperitoneal)
2 Recruiting Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer
Condition: Cervical Cancer
Interventions: Drug: Weekly cisplatin with RT;   Drug: Tri-weekly cisplatin with RT
3 Completed Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Biological: filgrastim;   Drug: cisplatin;   Drug: doxorubicin hydrochloride;   Drug: paclitaxel

Indicates status has not been verified in more than two years